PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 33,032 Shares of Company Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 33,032 shares of the company’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $41.13, for a total value of $1,358,606.16. Following the sale, the chief executive officer owned 54,522,217 shares in the company, valued at approximately $2,242,498,785.21. This trade represents a 0.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total value of $1,033,395.84.
• On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The shares were sold at an average price of $42.51, for a total value of $1,107,470.52.
• On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total value of $14,274.51.
• On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The shares were sold at an average price of $45.23, for a total value of $476,226.67.
• On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The stock was sold at an average price of $45.16, for a total value of $396,098.36.
• On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total transaction of $206,164.14.
• On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The stock was sold at an average price of $43.49, for a total transaction of $1,046,238.93.
• On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The shares were sold at an average price of $42.69, for a total transaction of $984,943.68.
• On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The shares were sold at an average price of $42.56, for a total transaction of $858,562.88.
• On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The stock was sold at an average price of $42.94, for a total transaction of $1,021,242.02.

PACS Group Trading Down 0.3%

Shares of PACS stock traded down $0.11 during trading hours on Monday, reaching $42.74. 844,528 shares of the stock were exchanged, compared to its average volume of 900,159. PACS Group, Inc. has a 12-month low of $10.31 and a 12-month high of $49.49. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. The company’s 50-day moving average price is $43.97 and its 200-day moving average price is $39.70. The firm has a market capitalization of $6.76 billion, a price-to-earnings ratio of 24.85, a price-to-earnings-growth ratio of 1.34 and a beta of -0.08.

PACS Group (NYSE:PACS) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.54 by $0.09. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. As a group, equities analysts anticipate that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Oppenheimer upped their target price on PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Zacks Research cut PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Royal Bank Of Canada upped their price objective on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. Truist Financial set a $62.00 target price on PACS Group in a research note on Wednesday, September 2nd. Finally, Wall Street Zen downgraded PACS Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 8th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, PACS Group has a consensus rating of “Moderate Buy” and an average target price of $58.80.

Hedge Funds Weigh In On PACS Group

A number of hedge funds have recently added to or reduced their stakes in the stock. Financial Management Professionals Inc. increased its position in shares of PACS Group by 54.9% during the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after acquiring an additional 235 shares during the period. KBC Group NV purchased a new stake in shares of PACS Group in the first quarter valued at approximately $42,000. Western Wealth Management LLC bought a new position in PACS Group in the first quarter worth approximately $48,000. Integrated Wealth Concepts LLC bought a new position in PACS Group in the second quarter worth approximately $75,000. Finally, Nykredit A S purchased a new position in PACS Group during the 2nd quarter worth $95,000.

PACS Group Company Profile

PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.

The company’s services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.